CE vs OMCL · rev $10.28B vs P/E 90, rev $1.11B
Celanese Corporation (CE) versus Omnicell Inc (OMCL) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Omnicell Inc (OMCL) is a health information services company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported OMCL revenue for 2024-12-31 was $1.11B. Net income was $12.5M. Revenue was down 3.0% from 2023-12-31 to 2024-12-31. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
CE currently screens at market cap $5.92B. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
Not investment advice. Open the CE and OMCL stock pages for the full models.
Not investment advice.